Results 41 to 50 of about 333 (103)

Treatment of flat warts with trifarotene

Dermatology Reports
This retrospective study explores the off-label use of trifarotene, a topical retinoid currently approved only for acne in individuals aged 12 years and older for the treatment of verrucae planae (flat warts).
Gaetano Licata, Eugenia Veronica Di Brizzi, Elisabetta Fulgione, Graziella Babino, Vittorio Tancredi, Filomena Barbato, Giuseppe Argenziano, Caterina Mariarosaria Giorgio   +7 more
doaj   +1 more source

Treatment of Acne Vulgaris With a 650-ms, 1064-nm Nd:YAG Laser: A Retrospective Study. [PDF]

J Cosmet Dermatol
ABSTRACT Background The 650‐ms, 1064‐nm Nd:YAG laser device may provide superior efficacy and tolerability for the treatment of acne vulgaris over conventional treatments. Aim To evaluate the efficacy and tolerability of a 650‐ms laser for the treatment of mild to severe facial acne vulgaris. Patients/Methods Records of 225 subjects with mild to severe
Olugbade ID, Petty AC, Imahiyerobo-Ip J.
europepmc   +2 more sources

Trifarotene phase 3 supplemental information

, 2019
Supplemental information for trifarotene phase III publication in Journal of American Academy of ...
Diane M. Thiboutot (782783), Alessandra Alio (6509468), Jerry Tan (6509470)   +2 more
core   +1 more source

Trifarotene Administration in the Patient with Acne Conglobata and Autoimmune Hepatitis: Case Study

Вопросы современной педиатрии
Background. Challenge in management of severe acne (conglobata, nodular) in patients with comorbid hepatopathy is associated to the high risk of systemic retinoids hepatotoxicity. Topical retinoid, trifarotene, as a selective RAR- (retinoic acid receptor)
Nikolay N. Murashkin, Leonid A. Opryatin, Olesya D. Dubenko, Dmitriy V. Fedorov, Alena A. Savelova   +4 more
doaj   +1 more source

Advances in Skin Whitening Agents: Mechanisms, Clinical Applications, and Future Perspectives

Journal of Cosmetic Dermatology, Volume 25, Issue 9, September 2026.
ABSTRACT Background Skin hyperpigmentation disorders are common cosmetic and clinical concerns caused by excessive melanin production, abnormal pigment distribution, or persistent pigment after inflammation. Their heterogeneous pathogenesis and tendency to recur complicate treatment, particularly in patients with darker phototypes.
Yuanyuan Chen, Enhui Wang, Yize Li, Yanfang Yang, Zhaofeng Zhang, Junbo Wang, Yanfei Jiang, Chunyue Zhao   +7 more
wiley   +1 more source

Trifarotene in the Treatment of Acne Vulgaris: Current Evidence and Place in Clinical Practice

Journal of Education, Health and Sport
Background: Acne vulgaris is a highly prevalent chronic inflammatory skin disease that significantly affects quality of life and psychological well-being.
Joanna Sowińska, Natalia Paluszkiewicz, Sandra Bryg, Aleksandra Cieślak, Sara Demkow, Zofia Leżańska, Mateusz Kwiatkowski, Katarzyna Marcinkowska, Karolina Siemińska, Emil Pałyga   +9 more
doaj   +1 more source

Keratinocyte‐Associated Biomarkers Reveal Pathogenic Mechanisms in Acne

FASEB BioAdvances, Volume 8, Issue 2, February 2026.
The study workflow integrates scRNA‐seq and bulk RNA‐seq data to characterize acne pathogenesis. Step 1 identifies expanded keratinocyte populations using single‐cell analysis. Step 2 filters candidate genes via WGCNA and differential expression integration.
Sini Cai, Yinjing Lin, Heng Xie, Xian Ao, Qiwei Liu, Lining Huang   +5 more
wiley   +1 more source

Trifarotene phase 3 study supplemental information

, 2019
Trifarotene phase 3 study supplemental information to accompany JAAD publication ...
Alio, A (via Mendeley Data)
core   +1 more source

Stability-indicating liquid chromatographic method development and validation for quantification of trifarotene in pure and topical drug product

Future Journal of Pharmaceutical Sciences
Background Trifarotene is effective for treating acne and other skin issues. To ensure its quality and meet regulatory standards, a reverse phase liquid chromatography (RP-LC) stability-indicating method was developed and validated for its quantification
Muhammad Usman, Muhammad Bilal Shafique
doaj   +1 more source

Trifarotene: first approval

, 2019
Compliance with Ethical Standards Funding The preparation of this review was not supported by any external funding. Conflicts of interest  During the peer review process the manufacturer of the agent under review was offered an opportunity to comment ...
Lesley J. Scott (4891801)
core   +1 more source